Quantum Cyber N.V. Proceeds From Exercise Of Warrants
Quantum Cyber N.V. (QUCY) reported Proceeds From Exercise Of Warrants of $382.50 thousand for the 12-month period ending 2022-12-31, per its 20-F filed 2025-03-31.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:ProceedsFromExerciseOfWarrants · last filed 2025-09-26
- Quantum Cyber N.V. proceeds from exercise of warrants for the quarter ending 2022-12-31 was $0.00.
- Quantum Cyber N.V. proceeds from exercise of warrants for the quarter ending 2022-09-30 was $0.00.
- Quantum Cyber N.V. proceeds from exercise of warrants for the quarter ending 2022-06-30 was $0.00.
- Quantum Cyber N.V. proceeds from exercise of warrants for the quarter ending 2022-03-31 was $382.50K.
| Period end | Proceeds From Exercise Of Warrants | Proceeds From Exercise Of Warrants 3 month | Proceeds From Exercise Of Warrants 6 month | Proceeds From Exercise Of Warrants 9 month | Proceeds From Exercise Of Warrants 12 month |
|---|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2025-03-31 | $0.00 derived: sum of 2 quarters · filed 2025-03-31 | $0.00 derived: sum of 3 quarters · filed 2025-03-31 | $382.50K 20-F · filed 2025-03-31 | |
| 2022-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2023-11-16 | $0.00 derived: sum of 2 quarters · filed 2023-11-16 | $382.50K 6-K · filed 2023-11-16 | ||
| 2022-06-30 | $0.00 derived: 6-K 6 month − 6-K 3 month · filed 2023-08-15 | $382.50K 6-K · filed 2023-08-15 | |||
| 2022-05-19 | $3.50M 6-K · filed 2025-09-26 | ||||
| 2022-03-31 | $382.50K 6-K · filed 2023-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |